Controlled trial with chloroquine diphosphate in systemic lupus erythematosus
- 1 June 1996
- journal article
- clinical trial
- Published by SAGE Publications in Lupus
- Vol. 5 (3) , 237-241
- https://doi.org/10.1177/096120339600500313
Abstract
Introduction: Antimalarials have been recognized as effective drugs for the treatment of articular and cutaneous manifestations of systemic lupus erythematosus (SLE), but its potential in the management of systemic features of the disease has not yet been thoroughly evaluated.Keywords
This publication has 14 references indexed in Scilit:
- Ophthalmologic safety of long-term hydroxychloroquine sulfate treatmentThe American Journal of Medicine, 1983
- Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapyThe American Journal of Medicine, 1983
- Risk/benefit analysis of hydroxychloroquine sulfate treatment in rheumatoid arthritisThe American Journal of Medicine, 1983
- Dose refinements in long-term therapy of rheumatoid arthritis with antimalarialsThe American Journal of Medicine, 1983
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Chloroquine retinopathy: is there a safe daily dose?Annals of the Rheumatic Diseases, 1982
- Ophthalmologic safety of long‐term hydroxychloroquine treatmentArthritis & Rheumatism, 1979
- Antimalarials in the management of discoid and systemic lupus erythematosusSeminars in Arthritis and Rheumatism, 1978
- RETINOPATHY FOLLOWING CHLOROQUINE THERAPYThe Lancet, 1959
- SYSTEMIC LUPUS ERYTHEMATOSUS: RECENT ADVANCES IN ITS DIAGNOSIS AND TREATMENTAnnals of Internal Medicine, 1956